Your browser doesn't support javascript.
loading
The potential long-term comparative effectiveness of larotrectinib vs standard of care for treatment of metastatic TRK fusion thyroid cancer, colorectal cancer, and soft tissue sarcoma.
Suh, Kangho; Carlson, Josh J; Xia, Fang; Williamson, Todd; Sullivan, Sean D.
Affiliation
  • Suh K; School of Pharmacy, University of Pittsburgh, PA.
  • Carlson JJ; Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle.
  • Xia F; Bayer U.S. LLC, Whippany, NJ.
  • Williamson T; Bayer U.S. LLC, Whippany, NJ.
  • Sullivan SD; Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle.
J Manag Care Spec Pharm ; 28(6): 622-630, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35362337
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Colorectal Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: J Manag Care Spec Pharm Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Colorectal Neoplasms Type of study: Prognostic_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: J Manag Care Spec Pharm Year: 2022 Document type: Article Affiliation country: Country of publication: